' Great Optimism ' Over Complete Responses in dMMR Rectal Cancer ' Great Optimism ' Over Complete Responses in dMMR Rectal Cancer
A small trial shows that patients with locally advanced rectal cancer and deficient mismatch repair tumors respond remarkably well to neoadjuvant PD-1 blockade with dostarlimab.Medscape Medical News
Source: Medscape General Surgery Headlines - Category: Surgery Tags: Hematology-Oncology News Source Type: news
More News: Cancer | Cancer & Oncology | Gastroschisis Repair | Hematology | Neoadjuvant Therapy | Rectal Cancers | Surgery